9th International Symposium on NeuroVirology

描述（由申请人提供）：本申请为第九届国际神经病毒学研讨会寻求支持，该会议将于2009年6月2日至6日在美国佛罗里达州迈阿密举行，为期3.5天，部分由国际神经病毒学学会（ISNV）赞助。这次专题讨论会将是1997年开始的系列讨论会中的第九次。具体来说，申请要求资金用于支付以下费用：(1)全体会议演讲者，(2)研讨会演讲者，(3)特别讲师，(4)研究生，博士后研究员和临床研究员的旅行补助金，(5)准备现场注册包材料，(6)海报会议费用，(7)租用视听设备，(8)租用研讨会和海报会议的房间，(9)与注册，计划准备相关的行政工作。摘要处理，一般性会议准备活动，以及（10）所有会议活动的网络管理。第九届国际神经病毒学研讨会的具体目的是提供一个论坛，传播有关以下方面的新信息：(1)HIV疾病和神经系统并发症(2)先天免疫和适应性免疫(3)神经艾滋病和轻微神经认知障碍(4)精神神经免疫学(5)嗜神经病毒的发病机制(6)嗜神经病毒的分子生物学(7)病毒库和潜伏期(8)动物模型和神经发病机制。(9)药物滥用和其他合并症，（10）宿主和病毒遗传学，（11）生物标志物和疾病预测和监测，（q14）衰老和神经退行性疾病，（13）长期抗逆转录病毒治疗的病理后果，（14）干细胞生物学和神经发生。第九届研讨会还将(1)加强关于预防和治疗由艾滋病毒和其他一些病毒和非病毒病原体引起的神经系统疾病的基础/临床科学概念的交流，(2)促进年轻研究人员对一个重要和不断发展的多学科研究领域的吸引力（研究人员培训会议和网络午餐）。(3)促进国际范围内的合作，包括培育世界欠发达地区的研究；(4)强调基本科学概念和教条的发展（科学范式建设讲座）；(5)强调杰出女性在生物医学科学发展中的主要贡献（杰出女性科学讲座）；(6)比尔·纳拉扬讲师奖，表彰在利用动物模型研制疫苗和治疗方法方面取得的重要成就。总的来说，第九届国际研讨会将寻求向神经病毒学和相关学科领域的研究人员提供最新的前沿信息，以便继续确定知识方面的重要空白。有了这些信息，与会者将努力制定新的问题和实验方向，以加强新策略的发展，以预防、诊断和治疗与朊病毒、HIV和其他病毒和非病毒病原体相关的神经系统疾病。预计约有350人将参加第九届研讨会，其中有250多篇摘要和50多篇口头报告。在第九届国际神经病毒学研讨会上提出和讨论的研究将集中在预防、诊断和治疗由病毒和其他非病毒传染病引起的人类神经系统疾病的新策略的发展。特别是，本次会议上的演讲、讨论、战略规划和合作科学将针对确定控制免疫系统的新策略，以优化不同年龄、性别和种族/种族背景的人类神经系统疾病的预防和治疗，并将首次集中在与神经病毒学相关的心理神经免疫学学科的选定方面。研讨会还将概述在神经艾滋病、神经病毒学和其他非病毒性中枢神经系统病原体引起的疾病方面正在进行的国际研究工作。

DESCRIPTION (provided by applicant): This application seeks support for the 9th International Symposium on NeuroVirology that will be held as a 3.5 day meeting scheduled for June 2-6, 2009 in Miami, Florida, USA, and sponsored, in part, by the International Society for NeuroVirology (ISNV). This symposium will be the ninth in a series that was initiated in 1997. Specifically, the application requests funding to cover the costs of (1) plenary session speakers, (2) workshop speakers, (3) special lecturers (4) travel grants for graduate students, postdoctoral fellows, and clinical fellows, (5) preparation of on-site registration packet materials, (6) poster session costs, (7) rental of audiovisual equipment, (8) rental of rooms for workshop and poster sessions, (9) administrative effort associated with registration, program preparation, abstract processing, and general meeting preparation activities, and (10) web-based management of all meeting activities. The specific aims of the 9th International Symposium on NeuroVirology are to provide a forum for the dissemination of new information related to (1) HIV disease and neurologic complications (2) Innate and adaptive immunity (3) NeuroAIDS and minor neurocognitive disorders (4) Psychoneuroimmunology (5) Pathogenesis of neurotropic viruses (6) Molecular biology of neurotropic viruses (7) Viral reservoirs and latency (8) Animal models and neuropathogenesis, (9) Substance abuse and other co-morbidities, (10) Host and viral genetics, (11) Biomarkers and disease prediction and monitoring, (q14 Aging and neurodegenerative disease, (13) Pathologic consequences of long-term antiretroviral therapy, and (14) Stem cell biology and neurogenesis. The 9th Symposium will also (1) enhance cross-fertilization of basic/clinical science concepts concerning prevention and treatment of neurologic disease caused by HIV and a number of other viral and non-viral pathogens, (2) facilitate the attraction of young investigators to an important and growing multi-disciplinary field of investigation (Investigators-in-Training sessions and networking lunches), (3) stimulate collaborations with an international scope including the nurturing of research in underdeveloped regions of the world, (4) emphasize the development of basic scientific concepts and dogma (Scientific Paradigm Building Lecture), (5) emphasize the major contributions of outstanding women in the development of biomedical science (Women's Excellence in Science Lecture), (6) Bill Narayan Lectureship to recognize important achievements in the use of animal models to develop vaccines and therapeutics. Overall, the 9th International Symposium will seek to update investigators working in the field of neurovirology and related disciplines with leading edge information so that important gaps in knowledge can continue to be identified. Armed with this information, attendees will work toward formulating new questions and experimental directions to enhance the development of new strategies to prevent, diagnose, and treat neurologic disease associated with prions, HIV, and other viral and non-viral pathogens. It is anticipated that approximately 350 individuals will attend the 9th Symposium with more than 250 abstracts and greater than 50 oral presentations. The research presented and discussed at the 9th International Symposium on NeuroVirology will focus on the development of new strategies to prevent, diagnose, and treat diseases of the human nervous system caused by viral and other non-viral infectious disease agents. In particular, the presentations, discussion, and strategic planning and collaborative science developed at this meeting will be directed at identifying new strategies to control the immune system to optimize the prevention and treatment of neurologic disease in humans of different ages, gender, and ethnic/racial backgrounds and will focus for the first time on selected aspects of the discipline of psychoneuroimmunology relevant to neurovirology. The Symposium will also overview ongoing international research efforts in NeuroAIDS, neurovirology, and diseases caused by other non-viral CNS pathogens.